Development of pharmaceutical care services in nursing homes: Practice and research in a Swiss canton

Pharmacy World and Science

Volumn 31, Issue 2, 2009, Pages 165-173

  Locca, Jean François ^a   Ruggli, Martine ^b   Buchmann, Michel ^c   Huguenin, Jacques ^d   Bugnon, Olivier ^a  

^a POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^b PharmaSuisse   (Switzerland)

^c Community Pharmacy Tête Noire ^*  (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Economic impact; Implementation; Nursing homes; Pharmaceutical care service; Switzerland

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MEDICAL PRACTICE; MEDICAL RESEARCH; NURSING HOME; PHARMACIST; PHARMACY; SWITZERLAND;

AGED; AGED, 80 AND OVER; DRUG COSTS; EDUCATION, PHARMACY, CONTINUING; FEMALE; HUMANS; MALE; NURSING HOMES; PHARMACY SERVICE, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; SWITZERLAND;

EID: 63049096547     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-008-9273-9     Document Type: Article

References (28)

1. Landefeld CS, Palmer R, Johnson MA, Johnston B, Lyons W. Current geriatric: diagnosis and treatment. New York: Lange Medical Books/McGraw-Hill; 2004. ISBN 0-07-139924-0.
2. Höpflinger F, Hugentobler V. Soins familiaux, ambulatoires et stationnaires des personnes âgées en Suisse-Observations et perspectives [Family, ambulatory and medical care for Swiss elderly patients-observations and perspectives]. Chêne-Bourg: Médecine et Hygiène; 2006. ISBN 2-88049-216-5.
3. E Guignard O Bugnon 2006 Pharmaceutical care in community pharmacies: practice and research in Switzerland Ann Pharmacother 40 512 7 10.1345/aph.1G199
4. JM Carmichael M Beth B Devine W Kelly L Ereshefsky W Linn G Stimmel 1997 Collaborative drug therapy management by pharmacists Pharmacotherapy 16 1050 61
5. Ruggli M, Buchmann M, Bugnon O. Pharmaceutical Services in Institutions for the Elderly: A Concrete Example for Community Pharmacists. In: Charlie Benrimoj editor. Proceedings of the 62nd world congress of pharmacy and pharmaceutical sciences, Community Pharmacy Section; 2002 September 4-5; Nice, France. 2002. p. 27-42.
6. Ruggli M, Buchmann M, Burgy I, Bugnon O. Action plan for the dissemination of a new pharmaceutical service in institutions for the elderly. In: Proceedings of the 63rd world congress of pharmacy and pharmaceutical sciences, Community Pharmacy Section. 2003 September 8-9; Sydney, Australia; 2003.
7. Fribourg health law. Loi du 16 novembre 1999 sur la santé [Legal update on health law-16 november 1999]. http://appl.fr.ch/sleg-bdlf/Result.aspx. Accessed 10 July 2008.
8. Fribourg health law. Loi du 28 novembre 2000 concernant les produits thérapeutiques [Law on therapeutic products-28 november 2000]. http://www.fr.ch/v-ofl-bdlf-courant/fra/8212021.pdf. Accessed 10 July 2008.
9. Fribourg health law. Ordonnance du 17 décembre 2002 approuvant la convention santésuisse et AFIPA ainsi que ses annexes I et II sur les soins dispensés dans les EMS fribourgeois [Agreement 2002 santésuisse-AFIPA (including appendices I and II) on health care provided in the Fribourg nursing homes]. http://admin.fr.ch/fr/data/pdf/publ/rof-2003/ 2003-021-f.pdf. Accessed 10 July 2008.
10. Swiss Association of Pharmacists. Dispositions générales et programme de formation complémentaire FPH en Assistance pharmaceutique d'établissements médico-sociaux (EMS) [Standard of practice and postgraduate training FPH in pharmaceutical care assistance service in nursing homes]. http://www.pharmasuisse.org/de/media/mehrsprachig/fahigkeitsprogramme/ heime/frz/02-Faehigkeitsprogramm-HEIME-Anhang-I-d-frz.pdf. Accessed 10 July 2008.
11. Health department of the canton of Fribourg. Cahier des charges du pharmacien-conseil de l'établissement [Content specification for the pharmacist working in a nursing home]. http://appl.fr.ch/ssp/formulaires/cahier- des-charges-du-pharmacien-conseil-version-definitive-aout-2007.pdf. Accessed 10 July 2008.
12. RW Holland CM Nimmo 1999 Transitions in pharmacy practice, part 3: effecting change-the three-ring circus Am J Health Syst Pharm 56 2235 41
13. F van Mil 2005 Barriers or facilitators? Pharm World Sci 27 69 10.1007/s11096-005-3344-y
14. AS Roberts SI Benrimoj TF Chen KA Williams TR Hopp P Aslani 2005 Understanding practice change in community pharmacy: a qualitative study in Australia Res Social Adm Pharm 1 546 64 10.1016/j.sapharm.2005.09.003
15. GC Chow 1960 Tests of equality between sets of coefficients in two linear regressions Econometrica 28 591 605 10.2307/1910133
16. DB Christensen KB Farris 2006 Pharmaceutical care in community pharmacies: practice and research in the US Ann Pharmacother 40 1400 6 10.1345/aph.1G545
17. C Eickhoff M Schulz 2006 Pharmaceutical care in community pharmacies: practice and research in Germany Ann Pharmacother 40 729 35 10.1345/aph.1G458
18. EJ Jones NJ Mackinnon RT Tsuyuki 2005 Pharmaceutical care in community pharmacies: practice and research in Canada Ann Pharmacother 39 1527 33 10.1345/aph.1E456
19. CG Ballard ML Margallo-Lana 2004 The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities J Clin Psychiatry 65 Suppl 11 23 8
20. SS Gill SE Bronskill SL Normand GM Anderson K Sykora K Lam 2007 Antipsychotic drug use and mortality in older adults with dementia Ann Intern Med 146 775 86
21. M Gobert W D'hoore 2005 Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland Int J Geriatr Psychiatry 20 712 21 10.1002/gps.1349
22. JW Kasckow JJ Mulchahey S Mohamed 2004 The use of novel antipsychotics in the older patient with neurodegenerative disorders in the long-term care setting J Am Med Dir Assoc 5 242 8
23. PA Rochon TA Stukel SE Bronskill T Gomes K Sykora WP Wodchis 2007 Variation in nursing home antipsychotic prescribing rates Arch Intern Med 167 676 83 10.1001/archinte.167.7.676
24. S Schneeweiss S Setoguchi A Brookhart C Dormuth PS Wang 2007 Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients CMAJ 27 176 627 32
25. LS Schneider KS Dagerman P Insel 2005 Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials JAMA 294 1934 43 10.1001/jama.294.15.1934
26. Locca JF, Favre M, Du Pasquier S, Zumbach S. Bugnon. Treatment safety in elderly patients with behavioral and psychological symptoms of dementia (BPSD): a retrospective analysis in nursing homes. World Congress of Pharmacy and Pharmaceutical Sciences-66th Congress of International Pharmaceutical Federation. Cairo: 2006.
27. JF Locca S Zumbach C Bula O Bugnon 2007 Du delirium au syndrome démentiel: prise en charge médicamenteuse dans les EMS fribourgeois Rev Med Suisse 3 2519 29 Management of elderly patients with delirium or dementia in Swiss nursing homes
28. JF Locca C Bula S Zumbach O Bugnon 2008 Pharmacological treatment of behavioral and psychological symptoms (BPSD) in nursing homes: development of practice recommendations in a Swiss Canton JAMDA 9 439 48 10.1016/j.jamda.2008. 04.003